Unilab Keeps Growing Keeps Growing Despite
Globalization
Jose Y. Campos
With more than 350 brands in 900
stock sizes, Unilab has a fifth of the local drug
market, despite being pitted against the world’s largest pharmaceutical
companies. Unilab has just opened a state-of-the-art
P1.5 billion manufacturing facility in Mamplasan and
Unilab keeps growing despite globalization, the entry of regional
brands and low-priced rivals, mergers among the drug giants, diminishing
purchasing power, and the emergence of private labels. In 2004, the company
launched 40 new products and in 2005, another 60 new products, including one
containing soluble calcium.
Many of Unilab’s
products are now leading brands not only in the
In business, JY believed in
meaningful relationships which he said should be for life. He also believed
that goodbyes should be better than hellos. As a boy, JY wanted to become a
military officer and passed the entrance exam at
JY’s success seems rooted in a very simple formula—produce quality medicines that are
priced reasonably, not burdened by heavy transfer pricing by multinationals. JY
picked his people well. CEO Doe Ejercito was a
celebrated Citibanker for his systems skills. JY
provided the people skills. Whenever JY hired a person, he asked his people
only one question: “Mabuting tao
ba ’yan [Is he a good
person]?” JY was a good person—humble, kind, caring, and hardworking. He is a
great loss to Philippine business and to the country.